| Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671) |
|---|
| 02/11/1997 | US5602013 Process for producing N-substituted-1-deoxynojirimycin |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 01/23/1997 | WO1997002277A2 Method for producing synthetic n-linked glycoconjugates |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/21/1997 | US5595977 Bactericides as antiulcer agents |
| 01/14/1997 | US5594155 Anomeric fluororibosyl amines |
| 01/14/1997 | US5593853 Displacemnt, oligomerization, reduction, alkylation, activation, protection, deprotection, oxidation, alkolation, thiolation, nitrilation, sulfitation, carbanation, fractionation and testing |
| 12/19/1996 | WO1996040169A1 Bacterial inhibition with an oligosaccharide compound |
| 12/19/1996 | CA2224102A1 Bacterial inhibition with an oligosaccharide compound |
| 12/18/1996 | EP0748328A1 Pseudoceramides |
| 12/18/1996 | EP0654087A4 A facile enzymatic synthesis of galactosyl-beta-1,3 glycals. |
| 12/17/1996 | US5585216 Improvers in electrographic toners and developers, in powder and powder coatings which can be sprayed triboelectrically or electrokinetically and in electret materials |
| 12/12/1996 | WO1996039160A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 12/12/1996 | WO1996039153A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/12/1996 | CA2222915A1 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 12/11/1996 | CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use |
| 12/10/1996 | US5583120 Applying to cutis tissues in treatment of dermatitis |
| 12/10/1996 | US5583119 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 12/10/1996 | US5583118 Topical application of mixture in carrier |
| 11/27/1996 | EP0743952A1 Generation and screening of synthetic drug libraries |
| 11/26/1996 | US5578719 Sulphonated derivatives of cyclomalto-oligosaccharides, their preparation process and support for active substances containing these derivatives |
| 11/19/1996 | US5576426 Aldolase catalyzed stereoselective synthesis of arabinohexulose, xyloheptulose, threohexulose and xylohexulose |
| 11/14/1996 | DE19618907A1 Aq. soln. of sec. amine |
| 11/13/1996 | CN1135756A Ganglioside GM3 analog Having sialic acid residue fluorinated at the 9-position and intermediate thereof |
| 11/12/1996 | CA2039249C Sulfonylphenyl-.beta.-d-thioxylosides, their method of preparation and their use in therapeutics |
| 11/07/1996 | WO1996034872A1 Iodine derivatives of monosaccharides useful as radiopharmaceutical products |
| 11/06/1996 | EP0741139A1 Sulphuric acid esters of amino sugars |
| 11/06/1996 | CA2174582A1 Sulphuric acid esters of amino-sugars |
| 10/31/1996 | WO1996034004A1 Sugar compounds |
| 10/31/1996 | DE19515212A1 Prodn. of radiofluorinated 2-fluoro-2-deoxy-glucose or -galactose |
| 10/23/1996 | EP0738155A1 Modular design and synthesis of oxazolone-derived molecules |
| 10/22/1996 | US5567686 Method for protection against genotoxic mutagenesis |
| 10/22/1996 | US5567683 Antiinflammatory agents |
| 09/26/1996 | WO1996029339A1 Fucopeptides |
| 09/26/1996 | CA2214107A1 Fucopeptides |
| 09/25/1996 | EP0732921A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/18/1996 | EP0731789A1 Dp-iv-serine protease inhibitors |
| 09/11/1996 | EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 09/11/1996 | EP0730566A1 Selectively fluorinated organic compounds |
| 09/04/1996 | EP0729473A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 08/28/1996 | EP0728763A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 08/27/1996 | US5550116 Anticoagulants |
| 08/27/1996 | US5550112 Skin ulcer therapy |
| 08/21/1996 | EP0727432A1 Process for the preparation of 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose |
| 08/14/1996 | EP0725786A1 Novel salts of amino glycosides |
| 08/08/1996 | WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc |
| 08/08/1996 | WO1996023479A2 Anti-adhesive active principles |
| 08/08/1996 | DE19503423A1 Antiadhäsive Wirkstoffe Anti-adhesive agents |
| 08/08/1996 | CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc |
| 08/04/1996 | CA2167895A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribopentofuranosyl) -cytosine from 2-deoxy-2, 2-difluoro-beta-d-ribo-pentopyranose |
| 07/30/1996 | US5541345 Anomeric fluororibosyl amines |
| 07/24/1996 | CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners |
| 07/23/1996 | US5538954 Sucrose octa-o-sulfonic acid salts of tetracyclines for inhibiting protein synthesis |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/03/1996 | EP0523186B1 Substance with lipo-oligosaccharide structure capable of acting as plant-specific symbiotic signals, processes for producing them and their applications |
| 06/25/1996 | US5529987 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 06/19/1996 | CN1032062C Asymmetric syntesis of 3-substituted furanoside compounds |
| 06/18/1996 | US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies |
| 06/12/1996 | EP0425601B1 Carbohydrateacryl- and methacrylcopolymers and their manufacture |
| 05/09/1996 | WO1996013258A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 05/02/1996 | WO1995034571A3 Drug salts |
| 04/24/1996 | EP0708110A2 Production of sucralose without intermediate isolation of crystalline sucralose-6-ester |
| 04/10/1996 | EP0642526A4 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose. |
| 03/19/1996 | US5500342 Method for determining sugar chain structure |
| 03/12/1996 | US5498709 Production of sucralose without intermediate isolation of crystalline sucralose-6-ester |
| 02/28/1996 | EP0698030A1 Preparation of fluoro-compounds |
| 02/22/1996 | WO1996005211A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 02/20/1996 | US5492821 Diagnostics, food industry |
| 02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
| 02/08/1996 | WO1996003357A1 Selectively fluorinated organic compounds |
| 01/31/1996 | CN1115763A Direct prodn process of 1-(D-ribamino)-3,4-dimethylbenzene |
| 01/30/1996 | US5488042 Method for protection against genotoxic mutagenesis |
| 01/17/1996 | EP0692475A1 N-METHYL-N-/$g(a),$g(D)-GLUCOPYRANOZIL/AMMONIA-2-/ACRIDON-9-ON-10-YL/ACETATE/CYCLOPHERONE, WITH INTERFERON PRODUCING, ANTI-VIRAL (INCLUDING ANTI-HIV), ANTI-PARASITIC, ANTI-PROMOTER AND RADIOPROTECTIVE PROPERTIES |
| 01/02/1996 | US5480992 Anomeric fluororibosyl amines |
| 12/21/1995 | WO1995034571A2 Drug salts |
| 12/20/1995 | EP0687959A1 Use of cyclic oligosaccharides or polysaccharides as charge control agents |
| 12/12/1995 | US5475094 Salmycins, a process for their preparation and their use as a pharmaceutical |
| 12/07/1995 | DE4418842A1 Colourless, thermostable, non-toxic cyclised oligo- or poly:saccharide use as charge controller or enhancer |
| 11/28/1995 | US5470842 Carbohydrate-based anti-inflammatory agents |
| 11/28/1995 | US5470578 Antirheumatic composition |
| 11/21/1995 | CA1337589C Unpleasant taste masking compositions and methods for preparing same |
| 10/23/1995 | CA2121952A1 Topical preparations for the treatment of acne and acneiform dermatitis |
| 10/18/1995 | EP0676963A1 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 09/26/1995 | US5453499 Process for preparing alpha-anomer enriched 1-halo-2-deoxy-2,2-difluoro-D-ribofuranosyl derivatives |
| 09/12/1995 | US5449772 Continuous process for the preparation of sucrose 6-esters |
| 09/08/1995 | WO1995023807A1 Pseudoceramides |
| 09/06/1995 | EP0669827A1 Compositions for the regulation of cytokine activity |
| 08/23/1995 | EP0641350A4 Method for making 2-fluoro-2-deoxyglucose. |
| 08/17/1995 | WO1995021850A1 Generation and screening of synthetic drug libraries |
| 08/15/1995 | US5441932 Antiallergens, antiinflammatory agents |
| 08/10/1995 | CA2211979A1 Tricyclic derivatives and their use as anti-cancer agents |
| 08/02/1995 | EP0517788B1 19 f labelled compounds as nmr imaging and spectroscopy agents |
| 08/02/1995 | CN1029405C Lipid A analogs having immunoactivating and antitumor activity |
| 07/25/1995 | US5436325 Method for making 2-fluoro-2-deoxyglucose |
| 07/19/1995 | CN1105367A Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 07/18/1995 | US5434266 Amidrazone derivatives |
| 07/11/1995 | US5432163 Treating inflammatory, autoimmune disorders |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |